How has been the historical performance of the Bayer CropSci.?
Bayer CropSci. has shown significant revenue growth, with net sales increasing from Rs 3,167.30 crore in Mar'19 to Rs 5,473.40 crore in Mar'25. However, rising expenditures have led to declines in operating profit, profit before tax, profit after tax, and earnings per share during the same period.
Answer:The historical performance of Bayer CropSci. shows a trend of increasing net sales and operating income over the years, with net sales rising from Rs 3,167.30 crore in Mar'19 to Rs 5,473.40 crore in Mar'25. The total operating income followed a similar trajectory, reaching Rs 5,473.40 crore in Mar'25, up from Rs 3,167.30 crore in Mar'19. However, the total expenditure also increased significantly, from Rs 2,686.20 crore in Mar'19 to Rs 4,783.80 crore in Mar'25, impacting the operating profit, which decreased from Rs 809.30 crore in Mar'24 to Rs 689.60 crore in Mar'25. Profit before tax showed a decline from Rs 941.40 crore in Mar'24 to Rs 707.40 crore in Mar'25, while profit after tax also fell from Rs 740.50 crore in Mar'24 to Rs 568.00 crore in Mar'25. The earnings per share decreased from Rs 164.92 in Mar'24 to Rs 126.5 in Mar'25, reflecting the overall decline in profitability. Breakdown:
Bayer CropSci. has demonstrated a consistent growth in net sales, which increased from Rs 3,167.30 crore in Mar'19 to Rs 5,473.40 crore in Mar'25, indicating a strong revenue growth trajectory. Despite this growth in sales, the total expenditure also rose significantly, leading to a decrease in operating profit from Rs 1,035.00 crore in Mar'24 to Rs 809.30 crore in Mar'25. This decline continued through to profit before tax, which fell from Rs 941.40 crore in Mar'24 to Rs 707.40 crore in Mar'25, and profit after tax, which decreased from Rs 740.50 crore to Rs 568.00 crore in the same period. The earnings per share reflected this downward trend, dropping from Rs 164.92 to Rs 126.5. Overall, while Bayer CropSci. has achieved substantial revenue growth, rising costs have adversely affected profitability in recent years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
